<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ACross-border_M%26A_%28insurance%29</id>
	<title>Definition:Cross-border M&amp;A (insurance) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ACross-border_M%26A_%28insurance%29"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Cross-border_M%26A_(insurance)&amp;action=history"/>
	<updated>2026-06-13T18:24:35Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Cross-border_M%26A_(insurance)&amp;diff=10160&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Cross-border_M%26A_(insurance)&amp;diff=10160&amp;oldid=prev"/>
		<updated>2026-03-11T06:58:41Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🌍 &amp;#039;&amp;#039;&amp;#039;Cross-border M&amp;amp;A (insurance)&amp;#039;&amp;#039;&amp;#039; describes mergers, acquisitions, and strategic investments in which at least one party — whether an [[Definition:Insurance carrier | insurer]], [[Definition:Reinsurance | reinsurer]], [[Definition:Insurance broker | broker]], or [[Definition:Insurtech | insurtech]] platform — is domiciled or substantially operates in a jurisdiction different from the other. These transactions are a defining feature of the global insurance landscape, driven by carriers seeking geographic diversification, [[Definition:Private equity | private equity]] sponsors assembling multi-country platforms, and [[Definition:Managing general agent (MGA) | MGAs]] expanding their [[Definition:Delegated underwriting authority (DUA) | delegated authority]] footprints across borders.&lt;br /&gt;
&lt;br /&gt;
⚙️ Executing a cross-border insurance deal requires navigating overlapping regulatory regimes simultaneously. On the competition side, the transaction may need clearance from the [[Definition:Federal Trade Commission (FTC) review | FTC]] or [[Definition:Department of Justice (DOJ) antitrust review | DOJ]] in the United States, the [[Definition:European Commission merger control | European Commission]] under the [[Definition:EU Merger Regulation | EU Merger Regulation]], and the [[Definition:Competition and Markets Authority (CMA) review | CMA]] in the United Kingdom — each applying its own [[Definition:Market concentration (insurance) | market-concentration]] tests and remedy frameworks. On the prudential side, every jurisdiction where the target holds an insurance license typically requires a separate change-of-control approval from the local [[Definition:Insurance regulator | insurance supervisor]] — whether that is a [[Definition:State insurance department | state insurance department]] in the U.S., a [[Definition:Solvency II | Solvency II]] national competent authority in Europe, or equivalent bodies in Asia-Pacific markets. Coordinating these parallel tracks, managing [[Definition:Multi-state regulatory approval | multi-state filings]], and reconciling divergent data requests are among the most complex execution challenges in the industry.&lt;br /&gt;
&lt;br /&gt;
💡 Beyond regulatory mechanics, cross-border insurance M&amp;amp;A raises substantive strategic questions about [[Definition:Capital management | capital fungibility]], [[Definition:Reinsurance | reinsurance]] optimization across entities, harmonization of [[Definition:Underwriting | underwriting]] guidelines, and cultural integration of [[Definition:Claims management | claims]] and distribution teams operating under different legal traditions. Deals that look compelling on a spreadsheet can falter when trapped capital in one jurisdiction cannot be redeployed, or when local [[Definition:Policyholder | policyholder]]-protection rules prevent the restructuring of legacy [[Definition:Book of business | books]]. Successful acquirers invest heavily in pre-signing regulatory mapping and post-closing integration planning tailored to each market&amp;#039;s insurance-specific requirements.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Multi-state regulatory approval]]&lt;br /&gt;
* [[Definition:EU Merger Regulation]]&lt;br /&gt;
* [[Definition:Competition and Markets Authority (CMA) review]]&lt;br /&gt;
* [[Definition:Federal Trade Commission (FTC) review]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:Insurance M&amp;amp;A]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>